The homecare sector represents a highly attractive market for acquisition, fueled by powerful demographic trends, particularly the aging American population. This macro-environment provides a structural tailwind for demand, bolstered by compelling evidence that home-based care is approximately 30 percent cheaper than institutional care. Investors are eager to capitalize on patient preference for care in familiar environments and the alignment with major payer goals, as both Medicare Advantage (MA) and Medicaid seek cost containment and improved outcomes.